BioCentury
ARTICLE | Financial News

Biotech index gains erased, fund flows into the red

February 10, 2018 12:56 AM UTC

The return of drug pricing rhetoric and global stock market volatility have rocked biotech indexes over the last two weeks, wiping out most of what had been strong year-to-date gains.

Fund flows into the space have also swung into the red over the same period...